New Search

If you are not happy with the results below please do another search

Generic filters

50 search results for:


Jazz Pharmaceuticals Lays Out Vision 2025

After a strong 2021 that included the acquisition of GW Pharmaceuticals, the approval of the acute lymphoblastic leukemia drug Rylaze and the achievement of $3 billion in annual revenue, Jazz Pharmaceuticals set the company’s sights on nearly doubling that return by 2025.


Newly Discovered Gene Doubles Severe COVID-19 Risk and WHO Updates Guidelines

The World Health Organization updated WHO’s treatment guidelines for COVID-19 for the eighth time, recommending baricitinib for individuals with severe COVID-19 when used with corticosteroids. In other news, researchers from the Medical University of Bialystok in Poland identified a gene that appears to double the risk of severe COVID-19.


J&J booster 85% effective against Omicron hospitalization, South Africa says

A Johnson and Johnson COVID-19 vaccine booster shot is 85 percent effective in protecting against being hospitalized by the Omicron variant for 1-2 months after the shot is received, the head of South Africa’s Medical Research Council (SAMRC) said on January 14.